---
title: Liver Organoid Biobank at SOT 2026 | Advancing Drug Discovery | HUB
description: Explore our latest publications from SOT 2026, featuring innovative research on liver organoids and drug toxicity assessment. Download our scientific posters for detailed insights.
---

[![hub-logo-white](https://resources.huborganoids.nl/hs-fs/hubfs/hub-logo-white.png?width=1600&height=283&name=hub-logo-white.png "hub-logo-white")](https://huborganoids.nl/)

![merk-m-logo-blue](https://resources.huborganoids.nl/hs-fs/hubfs/merk-m-logo-blue.png?width=728&height=225&name=merk-m-logo-blue.png)

![sot26](https://resources.huborganoids.nl/hs-fs/hubfs/sot26.png?width=513&height=98&name=sot26.png)

# It was a pleasure to connect with you at SOT 2026!

Scroll down to access some of  
our publications that might be of  
interest to you.

## Download our scientific posters

<https://resources.huborganoids.nl/hubfs/assets2024/Hub-Organoids-SOT-2026-Poster-Patient-Derived-Liver-Organoid-Biobank.pdf>

### POSTER 3693

Development and Characterization of a Patient-Derived Liver Organoid Biobank

[download now](https://resources.huborganoids.nl/hubfs/assets2024/Hub-Organoids-SOT-2026-Poster-Patient-Derived-Liver-Organoid-Biobank.pdf)

<https://resources.huborganoids.nl/hubfs/assets2024/Hub-Organoids-SOT-2026-Poster-Liver-SCO.pdf>

### POSTER 3710

Development of iPSC-Derived Human Liver Organoids for Preclinical Drug

[download now](https://resources.huborganoids.nl/hubfs/assets2024/Hub-Organoids-SOT-2026-Poster-Liver-SCO.pdf)

<https://resources.huborganoids.nl/hubfs/assets2024/Hub-Organoids-SOT-2026-Poster-Human-Liver-Organoid-System.pdf>

### POSTER 3708

Human Liver Organoid Systems: Advancing Drug Toxicity Assessment

[download now](https://resources.huborganoids.nl/hubfs/assets2024/Hub-Organoids-SOT-2026-Poster-Human-Liver-Organoid-System.pdf)

<https://resources.huborganoids.nl/hubfs/assets2024/Hub-Organoids-SOT-2026-Poster-bridging-the-gap.pdf>

### POSTER 4113

Bridging the Gap Between *In Vitro* Models and Human Physiology: The Advantages of HUB’s Intestinal Patient-Derived Organoids in Toxicology

[download now](https://resources.huborganoids.nl/hubfs/assets2024/Hub-Organoids-SOT-2026-Poster-bridging-the-gap.pdf)

<https://resources.huborganoids.nl/hubfs/assets2024/Hub-Organoids-SOT-2026-Poster-Bioconvergence.pdf>

### POSTER J653

Harnessing Bioconvergence to Advance Organ-on-a-Chip Technology and Help Transform Drug Discovery & Development

[download now](https://resources.huborganoids.nl/hubfs/assets2024/Hub-Organoids-SOT-2026-Poster-Bioconvergence.pdf)

×

### Fill in your details

 

![Logo HUB Organoids](https://resources.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "Logo HUB Organoids")

[Privacy Policy](https://huborganoids.nl/privacy-policy)

HUB Organoids is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany

***FOR RESEARCH USE ONLY.**  Unless otherwise stated in our catalog or other company documentation  
 accompanying the product(s), our products are intended for research use only and are not to be used   
 for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro   
 diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to   
humans or animals.*